Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy
Clinical trial NCT06029595 · TERMINATED
Trial details
- NCT number
- NCT06029595
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-26
- Primary completion
- 2025-12-09
- Enrollment
- 517
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.